STAAR Surgical (STAA) reported Q2 preliminary net sales late Thursday of more than $90 million, up from $44.3 million a year earlier.
Analysts polled by FactSet are looking for $90.2 million.
Net sales in the Middle East, certain parts of the EMEA and Asia-Pacific regions, were affected by geopolitical and macro headwinds, the company said, adding that, if the conditions persist or worsen, its sales growth could continue to be negatively affected.
Shares were down about 13% in after-hours trading.